Company Monitoring Page for InterMune

latest headlines for company on cafepharma

Former Biotech CEO Asks Supreme Court To Review Free Speech Rights
Pharmalot
Thu, 08/8/13 - 02:40 pm
Tags:
InterMune, idiopathic pulmonary fibrosis, free speech, Actimmune
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
Tags:
TearLab, Array Biopharma, Furiex Pharmaceuticals, InterMune, Prosensa, Boston Scientific, Orexigen, Momenta, Ironwood, INSYS Therapeutics, Sequenom, OncoMed, Abraxis, Sarepta, Epizyme, Tesaro, Synta Pharmaceuticals, Bluebird Bio, Exelixis, Lexicon Pharmaceuticals, Intercept Pharma, GTx
InterMune Successfully Entering Huge Niche Market Unchallenged
Seeking Alpha
Sun, 07/28/13 - 11:18 am
Tags:
InterMune, Esbriet, idiopathic pulmonary fibrosis
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 07/27/13 - 11:16 am
Tags:
Array Biopharma, Prosensa, InterMune
Biotech Stocks Under Pressures, Focus On IPOs
Property Mentor Group
Fri, 07/26/13 - 11:37 am
Tags:
IPOs, Sequenom, Invovio, Aeterna Zentaris, Sarepta, InterMune, Cryolife, BiogenIdec, Boston Scientific, Varian Medical, Warner Chilcott
5 Drugmakers With a Lot on the Line Next Week
Motley Fool
Sun, 07/21/13 - 11:37 am
Tags:
Eli Lilly, InterMune, Gilead Sciences, Alexion, Biomarin
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Mon, 07/15/13 - 11:21 am
Tags:
Vivus, Trius Therapeutics, Prosensa, Pharmacyclics, NxStage Medical, Natus Medical, MiMedx, Merrimack Pharmaceuticals, Intuitive Surgical, InterMune, GTx, Fluidigm, Epizyme, Celldex, Astex, Analogic, Amarin, Alnylam, Alexion, AcelRx
10 Most-Shorted Biotech Stocks of 2013
TheStreet.com
Thu, 06/20/13 - 12:24 pm
Tags:
InterMune, Hyperion, Arena Pharmaceuticals, Sunesis, Synta Pharmaceuticals, Ziopharm, MannKind, Dendreon, Spectrum Pharmaceuticals, Sarepta Therapeutics
SEC settles with ex-InterMune controller over tip to friend
Reuters
Sat, 06/8/13 - 09:32 am
Tags:
InterMune, legal, SEC, insider trading
SEC Sues Ex-InterMune Finance Chief Alleging Esbriet Tips
Bloomberg
Fri, 06/7/13 - 10:21 am
Tags:
SEC, InterMune, Esbriet
2 Biotechs To Avoid, 1 To Buy
Motley Fool
Sun, 05/5/13 - 10:46 am
Tags:
Aveo Pharmaceuticals, InterMune, Galena Biopharma
Former Intermune CEO Loses Free Speech Appeal
Pharmalot
Wed, 03/6/13 - 11:21 am
Tags:
InterMune, off-label, legal
InterMune Earnings: Here’s Why Shares are Up Now
Wall St. Cheat Sheet
Fri, 02/22/13 - 11:10 am
Tags:
earnings, InterMune
InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A
Bloomberg
Wed, 02/20/13 - 12:13 pm
Tags:
FDA, InterMune, M&A, Esbriet
Forbes Earnings Preview: InterMune, Inc.
Forbes
Sat, 02/16/13 - 11:21 am
Tags:
InterMune, earnings
InterMune will sell $85M in debt and 12.5M shares of its stock to fund studies, marketing
Yahoo/AP
Tue, 01/15/13 - 11:38 am
Tags:
InterMune, stock offering
InterMune says 4Q lung disease drug sales improved
Yahoo/AP
Fri, 01/4/13 - 11:34 am
Tags:
earnings, InterMune
Rejection of InterMune’s Drug Told Early to FDA Advisers
Bloomberg
Wed, 12/26/12 - 09:23 am
Tags:
FDA, InterMune, Esbriet, IPF
SAC Scrutiny Intensifies as U.S. Probes InterMune Trading
Bloomberg
Mon, 12/10/12 - 11:59 am
Tags:
InterMune
SAC Capital’s InterMune Trades Said to Be Probed by FBI
Bloomberg
Sat, 12/8/12 - 11:03 am
Tags:
InterMune

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.